THIORIDAZINE ORAL SUS 2MG/ML DIN 00238775
Health Canada record
| Active ingredient(s) | THIORIDAZINE 2 MG |
|---|---|
| Dosage form | Suspension |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AC02 THIORIDAZINE |
| Original market date | 31-Dec-1972 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing THIORIDAZINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00027375 | MELLARIL | NOVARTIS PHARMACEUTICALS CANADA INC | Suspension | THIORIDAZINE 10 MG | Cancelled Post Market |
| 02229553 | NOVO-RIDAZINE (THIORIDAZINE ORAL SUSPENSION) - 2 MG/ML | NOVOPHARM LIMITED | Suspension | THIORIDAZINE 2 MG | Cancelled Post Market |
International API supply for THIORIDAZINE
1 active FDA Drug Master Files.
Request a quote for THIORIDAZINE ORAL SUS 2MG/ML